ALXO
ALX ONCOLOGY HOLDINGS INC
NASDAQ · Healthcare · Biotechnology · US
$1.14
+7.55%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -5.4%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.14 | -$0.13 | Beat 9.04% | — |
| May 8, 2026 | -$0.15 | -$0.17 | Miss -13.33% | — |
| Nov 7, 2025 | -$0.37 | -$0.41 | Miss -10.81% | — |
| Aug 12, 2025 | -$0.46 | -$0.49 | Miss -6.52% | — |
| May 8, 2025 | -$0.47 | -$0.58 | Miss -23.40% | — |
| Mar 6, 2025 | -$0.72 | -$0.55 | Beat 23.61% | — |
| Nov 7, 2024 | -$0.78 | -$0.58 | Beat 25.64% | — |
| May 9, 2024 | -$0.87 | -$0.71 | Beat 18.39% | — |
| Mar 7, 2024 | -$0.84 | -$0.93 | Miss -10.71% | $2.5M |
| Nov 13, 2023 | -$0.86 | -$1.24 | Miss -44.19% | — |
| Aug 10, 2023 | -$0.85 | -$0.84 | Beat 1.18% | — |
| May 11, 2023 | -$0.84 | -$0.58 | Beat 30.95% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026